Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone dose-finding with low-dose bupivacaine spinal anesthesia for cesarean section
ChiCTR2400088968Phase 4Completed
- Sponsor
- Ganzhou People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone and bupivacaine in postoperative pain and perioperative pain (3 arms), sponsored by Ganzhou People's Hospital. Primary endpoints: Incidence of intraoperative adverse reactions, Heart rate, blood pressure, and oxygen saturation during anesthesia and 5 more. Started Aug 2024; status: completed.
02
Drugs
hydromorphonebupivacaine
03
Conditions
postoperative painperioperative pain
Beyond the preview
Go deeper on ChiCTR2400088968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088968.